$7.30 -0.10 (-1.35%)
12/3/2009 4:00 PM

Orexigen Therapeutics, Inc. (OREX)

CAPS Rating: 2 out of 5

A biopharmaceutical company focused on the development of pharmaceutical product candidates for the treatment of central nervous system, disorders, with an initial focus on obesity.

Recs

1
Member Avatar fiordwalker (< 20) Submitted: 3/25/2008 3:23:03 PM : Outperform Start Price: $10.44 OREX Score: -14.72

weight loss drug could be a blockbuster

Report this Post 0 Comments

Featured Broker Partners